Racial Disparities Seen for Locally Advanced Rectal Cancer Outcomes
By Lori Solomon HealthDay Reporter
THURSDAY, March 7, 2024 -- Treatment outcomes for locally advanced rectal cancer (LARC) are less favorable for Hispanic and non-Hispanic Black patients versus non-Hispanic White patients, according to a study published online Feb. 29 in JAMA Network Open.
Rebecca M. Shulman, M.D., from the Fox Chase Cancer Center in Philadelphia, and colleagues assessed whether racial and ethnic disparities in treatment outcomes among patients with LARC could be accounted for by social determinants of health and demographic, clinical, and pathologic factors known to be associated with treatment response. The analysis included 34,500 patients with T3 to T4 or N1 to N2 LARC treated with neoadjuvant therapy and surgery (2004 through 2017).
The researchers found that Hispanic patients achieved tumor downstaging (48.9 versus 51.8 percent) and pN0 status (66.8 versus 68.8 percent) less often than non-Hispanic White patients. Black race, but not Hispanic ethnicity, was associated with less tumor downstaging (odds ratio [OR], 0.86), less frequent pN0 status (OR, 0.91), and less frequent pathologic complete response (pCR; OR, 0.81). A reduced rate of pCR was also associated with rural location (OR, 0.80), lack of or inadequate insurance (OR for Medicaid, 0.86; OR for no insurance, 0.65), and treatment in a low-volume center (OR for first quartile, 0.73; OR for second quartile, 0.79; OR for third quartile, 0.86).
"These findings suggest that racial and ethnic disparities in LARC treatment outcomes may be multifactorial, with an independent association with non-Hispanic Black race, suggesting unidentified biological variables or social determinants of health that warrant exploration," the authors write.
Several authors disclosed ties to relevant organizations.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Multifrequency Tympanometry Could Aid Diagnosis of Meniere Disease
MONDAY, May 6, 2024 -- Multifrequency tympanometry (MFT) could aid the diagnosis of Meniere disease (MD), according to a review published online March 4 in the Journal of...
Pediatric ED Length of Stay Reduced With Observation Unit for Mental Health
MONDAY, May 6, 2024 -- Children with mental health emergencies presenting to the pediatric emergency department (PED) who receive psychiatric comanagement in a pediatric...
Exposure to Food Additive Emulsifiers Linked to Risk for Type 2 Diabetes
MONDAY, May 6, 2024 -- Exposure to food additive emulsifiers is associated with an increased risk for type 2 diabetes, according to a study published in the May issue of The...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.